<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <billNumber>6574</billNumber>
    <createDate>2018-07-27T07:10:58Z</createDate>
    <updateDate>2020-12-05T11:28:29Z</updateDate>
    <originChamber>House</originChamber>
    <billType>HR</billType>
    <introducedDate>2018-07-26</introducedDate>
    <congress>115</congress>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 164, Number 126 (Thursday, July 26, 2018)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Ms. SCHAKOWSKY:H.R. 6574.Congress has the power to enact this legislation pursuantto the following:Pursuant to Article I, Section 8, Clause 3 of the UnitedStates Constitution[Page H7726]</pre>]]></constitutionalAuthorityStatementText>
    <recordedVotes />
    <committees>
      <billCommittees>
        <item>
          <systemCode>hswm00</systemCode>
          <name>Ways and Means Committee</name>
          <chamber>House</chamber>
          <type>Standing</type>
          <subcommittees>
            <item>
              <systemCode>hswm02</systemCode>
              <name>Health Subcommittee</name>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2018-08-13T17:48:00Z</date>
                </item>
              </activities>
            </item>
          </subcommittees>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2018-07-26T13:02:30Z</date>
            </item>
          </activities>
        </item>
        <item>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
          <chamber>House</chamber>
          <type>Standing</type>
          <subcommittees>
            <item>
              <systemCode>hsif14</systemCode>
              <name>Health Subcommittee</name>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2018-07-27T17:45:38Z</date>
                </item>
              </activities>
            </item>
          </subcommittees>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2018-07-26T13:02:25Z</date>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <committeeReports />
    <relatedBills />
    <actions>
      <item>
        <actionDate>2018-08-13</actionDate>
        <committees>
          <item>
            <systemCode>hswm02</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2018-07-27</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2018-07-26</actionDate>
        <links />
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hswm00</systemCode>
            <name>Ways and Means Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2018-07-26</actionDate>
        <links />
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2018-07-26</actionDate>
        <links />
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees />
      </item>
      <item>
        <actionDate>2018-07-26</actionDate>
        <links />
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees />
      </item>
      <actionTypeCounts>
        <placeholderTextForH>2</placeholderTextForH>
        <billReferrals>2</billReferrals>
        <introducedInTheHouse>1</introducedInTheHouse>
        <introducedInHouse>1</introducedInHouse>
      </actionTypeCounts>
      <actionByCounts>
        <houseOfRepresentatives>6</houseOfRepresentatives>
      </actionByCounts>
    </actions>
    <sponsors>
      <item>
        <bioguideId>S001145</bioguideId>
        <fullName>Rep. Schakowsky, Janice D. [D-IL-9]</fullName>
        <firstName>JANICE</firstName>
        <middleName>D.</middleName>
        <lastName>SCHAKOWSKY</lastName>
        <party>D</party>
        <state>IL</state>
        <identifiers>
          <lisID>1588</lisID>
          <bioguideId>S001145</bioguideId>
          <gpoId>7929</gpoId>
        </identifiers>
        <district>9</district>
        <byRequestType />
      </item>
    </sponsors>
    <cosponsors />
    <cboCostEstimates />
    <laws />
    <notes />
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Congressional oversight</name>
          </item>
          <item>
            <name>Government studies and investigations</name>
          </item>
          <item>
            <name>Health care coverage and access</name>
          </item>
          <item>
            <name>Medicare</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <actionDate>2018-07-26</actionDate>
          <actionDesc>Introduced in House</actionDesc>
          <lastSummaryUpdateDate>2019-08-05T18:22:52Z</lastSummaryUpdateDate>
          <text><![CDATA[<p><strong>Medicare Fair Drug Pricing Act of </strong><b>2018</b></p> <p>This bill requires the Centers for Medicare &amp; Medicaid Services (CMS) to negotiate with drug manufacturers in determining the price that may be charged for prescription drugs under the Medicare prescription drug benefit.</p> <p>Under current law, the CMS may not interfere with negotiations between drug manufacturers and prescription drug plan (PDP) sponsors. The bill creates an exception to this prohibition with respect to specified drugs that: (1) are single-source or biological, (2) are not both manufactured by more than two drug manufacturers&nbsp;and manufactured by at least one manufacturer as a generic drug, and (3) meet other specified requirements. The CMS must promulgate regulations regarding the identification of such drugs.</p> <p>With respect to&nbsp;these drugs, the CMS shall negotiate the price that may be charged to PDP sponsors and Medicare Advantage (MA) organizations for Medicare and MA enrollees. The bill establishes processes for negotiation and price determination in the initial plan year and subsequent plan years.</p> <p>A manufacturer must participate in the negotiation process as a condition of coverage under the Medicare prescription drug benefit.</p>]]></text>
          <updateDate>2018-07-26T04:00:00Z</updateDate>
          <name>Introduced in House</name>
        </item>
      </billSummaries>
    </summaries>
    <title>Medicare Fair Drug Pricing Act of 2018</title>
    <titles>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <parentTitleType />
        <title>Medicare Fair Drug Pricing Act of 2018</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType />
        <title>To amend part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to determine, on behalf of Medicare beneficiaries, covered part D drug prices for certain covered part D drugs, and for other purposes.</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <parentTitleType />
        <title>Medicare Fair Drug Pricing Act of 2018</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Display Title</titleType>
        <parentTitleType />
        <title>Medicare Fair Drug Pricing Act of 2018</title>
        <chamberCode />
        <chamberName />
      </item>
    </titles>
    <amendments />
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2018-07-26T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-115hr6574ih/xml/BILLS-115hr6574ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2018-08-13</actionDate>
      <text>Referred to the Subcommittee on Health.</text>
      <links />
    </latestAction>
    <calendarNumbers />
    <version>1.0.0</version>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

